Author: BMR

The Venture has pushed above its 50-day moving average for the first time in 3 months as seasonal strength kicks in, and CanniMed Therapeutics opens on the TSX after a $60 million IPO…

Read More

The Venture tries to push off a near 6-month low of 711 last week to finish a successful 2016 with a flurry, while Canadian Zeolite lays out aggressive plans for 2017…

Read More

Another Venture junior gets swallowed by a bigger fish while President-elect Trump’s nuclear tweet gives Uranium stocks another boost…

Read More

Canopy Growth closes a $60 million financing, IAMGOLD takes over Merrex Gold while another junior with a high-grade Gold deposit says it’ll listen to offers…

Read More